Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulphadoxine-Pyrimethamine versus Dihydroartemisinin-Piperaquine for intermittent preventive therapy in pregnancy-associated malaria
PACTR201701001982152Not yet recruiting
- Sponsor
- Babcock University
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dihydroartemisinin + piperaquine and sulfadoxine + pyrimethamine in malaria (2 arms), sponsored by Babcock University. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
dihydroartemisinin + piperaquinesulfadoxine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR201701001982152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201701001982152.